MedPath

Monitoring of Fetal Lung Elasticity by Elastography Between 24 and 39 Weeks

Not Applicable
Completed
Conditions
Pregnant Woman
Registration Number
NCT03834805
Lead Sponsor
Centre Hospitalier Universitaire de Besancon
Brief Summary

The objective of the study is to evaluated the evolution of the LLE ratio (Lung to Liver Elastography ratio) during normal pregnancy

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
74
Inclusion Criteria
  • major pregnant women
  • singleton pregnancy
Exclusion Criteria

foetus:

  • fetal pulmonary disease
  • fetal liver disease
  • chromosome fetal abnormalities
  • fetal growth restriction

mother:

  • BMI>30 in beginning of pregnancy
  • premature ruptured membranes
  • high blood pressure
  • pre-eclampsia
  • gestational diabetes

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Change of Lung to liver Elastography ratio (LLE ratio) between 24 and 39 weeks of amenorrheameasurements at: 24, 28, 32, 36, 39 weeks of amenorrhea (WA)

Evolution of the fetal lung elasticity coefficient measured in kilopascals (kPa) compared to the fetal liver elasticity

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CHU Jean Minjoz

🇫🇷

Besançon, Doubs, France

CHU Jean Minjoz
🇫🇷Besançon, Doubs, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.